As on July 12, 2021, OncoSec Medical Incorporated (NASDAQ: ONCS) started slowly as it slid -5.90% to $2.71. During the day, the stock rose to $2.87 and sunk to $2.68 before settling in for the price of $2.88 at the close. Taking a more long-term approach, ONCS posted a 52-week range of $1.91-$8.16. Meanwhile, its Annual Earning per share during the time was 31.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 40.50%. This publicly-traded company’s shares outstanding now amounts to $37.34 million, simultaneously with a float of $25.34 million. The organization now has a market capitalization sitting at $117.61 million. At the time of writing, stock’s 50-day Moving Average stood at $3.66, while the 200-day Moving Average is $4.94.
OncoSec Medical Incorporated (ONCS) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. OncoSec Medical Incorporated’s current insider ownership accounts for 5.20%, in contrast to 19.50% institutional ownership. According to the most recent insider trade that took place on Jun 28, this organization’s Interim CEO sold 13,613 shares at the rate of 3.16, making the entire transaction reach 43,017 in total value, affecting insider ownership by 178,387. Preceding that transaction, on May 03, Company’s VP, Finance sold 453 for 4.86, making the whole transaction’s value amount to 2,202. This particular insider is now the holder of 24,980 in total.
OncoSec Medical Incorporated (ONCS) Earnings and Revenue Records
This company achieved a return on equity of -221.51.
OncoSec Medical Incorporated’s EPS increase for this current 12-month fiscal period is 40.50% and is forecasted to reach -1.04 in the upcoming year.
OncoSec Medical Incorporated (NASDAQ: ONCS) Trading Performance Indicators
Let’s observe the current performance indicators for OncoSec Medical Incorporated (ONCS). It’s Quick Ratio in the last reported quarter now stands at 9.80. The Stock has managed to achieve an average true range (ATR) of 0.31.
In the same vein, ONCS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.51, a figure that is expected to reach -0.29 in the next quarter, and analysts are predicting that it will be -1.04 at the market close of one year from today.
Technical Analysis of OncoSec Medical Incorporated (ONCS)
Through scrutinizing the latest numbers posted by the [OncoSec Medical Incorporated, ONCS], it can be observed that its last 5-days Average volume of 18.39 million was better the volume of 0.93 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 18.06% While, its Average True Range was 0.35.
Raw Stochastic average of OncoSec Medical Incorporated (ONCS) in the period of the previous 100 days is set at 1.71%, which indicates a major fall in contrast to 4.64% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 113.91% that was higher than 76.26% volatility it exhibited in the past 100-days period.